Business
US FDA approves use of Gilead’s remdesivir for hospitalised coronavirus patients – ABC News
The US Food and Drug Administration approves Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and…
The US Food and Drug Administration has approved Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the United States.
- The FDA’s formal approval for remdesivir’s widespread use came hours before the final presidential debate
- However, the World Health Organization found the drug did not have a substantial effect on patients’ length of hospital stays or chances of survival
- Remdesivir will be sold…
Continue Reading
-
General24 hours agoThis isn’t progress, it’s punishment
-
General23 hours agoMitch Marsh inspires Australia to three-wicket win over New Zealand in third T20I
-
General22 hours agoNothing to see here *wink wink*
-
General21 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup